Diabetic vascular complications

被引:48
作者
Cooper, ME
Gilbert, RE
Jerums, G
机构
来源
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 1997年 / 24卷 / 9-10期
关键词
aminoguanidine; diabetes; glycation; hypertension; nephropathy; retinopathy; vasculopathy;
D O I
10.1111/j.1440-1681.1997.tb02130.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Diabetic vascular complications can be arbitrarily divided into micro-and macrovascular complications, the major microvascular complications being nephropathy, retinopathy and neuropathy, Macrovascular complications are due to accelerated atherosclerosis and include ischaemic heart disease, cerebrovascular disease and peripheral vascular disease, 2. It is postulated that metabolic and haemodynamic factors interact leading to the development of diabetic vascular complications, 3. Advanced glycation appears to be an important pathway in the pathogenesis of diabetic complications with evidence that the inhibitor of this process, aminoguanidine, attenuates the development of a range of diabetic vascular complications, 4. The results of experimental studies have led to large-scale clinical trials of various therapeutic agents that act to interfere with the metabolic and haemodynamic pathways implicated in the progression of diabetic complications.
引用
收藏
页码:770 / 775
页数:6
相关论文
共 65 条
[1]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[2]   RENAL RENIN-ANGIOTENSIN SYSTEM IN DIABETES - FUNCTIONAL, IMMUNOHISTOCHEMICAL, AND MOLECULAR BIOLOGICAL CORRELATIONS [J].
ANDERSON, S ;
JUNG, FF ;
INGELFINGER, JR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04) :F477-F486
[3]   EFFECT OF PUBERTY ON INITIAL KIDNEY GROWTH AND RISE IN KIDNEY IGF-I IN DIABETIC RATS [J].
BACH, LA ;
JERUMS, G .
DIABETES, 1990, 39 (05) :557-562
[4]   REDUCED GLOMERULAR ANGIOTENSIN-II RECEPTOR DENSITY IN EARLY UNTREATED DIABETES-MELLITUS IN THE RAT [J].
BALLERMANN, BJ ;
SKORECKI, KL ;
BRENNER, BM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 247 (01) :F110-F116
[5]  
BERKA JL, 1995, INVEST OPHTH VIS SCI, V36, P1450
[6]  
BORDER WA, 1994, CONTRIB NEPHROL, V107, P140
[7]   AMINOGUANIDINE PREVENTS DIABETES-INDUCED ARTERIAL-WALL PROTEIN CROSS-LINKING [J].
BROWNLEE, M ;
VLASSARA, H ;
KOONEY, A ;
ULRICH, P ;
CERAMI, A .
SCIENCE, 1986, 232 (4758) :1629-1632
[8]   LILLY LECTURE 1993 - GLYCATION AND DIABETIC COMPLICATIONS [J].
BROWNLEE, M .
DIABETES, 1994, 43 (06) :836-841
[9]   Advanced glycosylation end products in diabetic renal and vascular disease [J].
Bucala, R ;
Vlassara, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (06) :875-888
[10]   CIRCULATING AND TISSUE ANGIOTENSIN SYSTEMS [J].
CAMPBELL, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (01) :1-6